Thierry Bogaert

From Wikipedia, the free encyclopedia

Thierry Bogaert is a Belgian scientist and businessman. He is one of the cofounders of the Belgian biotech company DevGen.

Contents 1 Education 2 Career 3 References 4 Source

[edit] Education

He graduated from the University of Ghent (Ghent, Belgium) and received an MSc degree form the University of Manitoba (Winnipeg, Canada). He obtained a PhD at the Laboratory of Molecular Biology, Medical Research Council, (Cambridge, United Kingdom).

[edit] Career

As an academic, he held faculty positions at the Laboratory of Molecular Biology of the Medical Research Council (MRC-LMB) in Cambridge and the Medical Faculty of the University of Ghent. His research interest was about Drosophila melanogaster integrins^[1][2] and the Caenorhabditis elegans UNC gene (uncoordinated phenotype) ^[3]

In 1997, he founded DevGen and became its Chief Executive Officer.

[edit] References

1. ^ Bogaert T, Brown N, Wilcox M, The Drosophila PS2 antigen is an invertebrate integrin that, like the fibronectin receptor, becomes localized to muscle attachments, Cell. 1987 Dec 24;51(6):929-40
2. ^ Leptin M, Bogaert T, Lehmann R, Wilcox M, The function of PS integrins during Drosophila embryogenesis, Cell. 1989 Feb 10;56(3):401-8
3. ^ Stringham E, Pujol N, Vandekerckhove J, Bogaert T, unc-53 controls longitudinal migration in C. elegans, Development. 2002 Jul;129(14):3367-79

[edit] Source

• Gents biotechbedrijf laat insecten zelfmoord plegen
• Thierry Bogaert